Clinical Trial Update: Safety of Exercise and High-dose Salbutamol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Receiving Therapeutic Doses of Indacaterol (QAB 149) and Salmeterol [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety of exercise with high-dose salbutamol in COPD patients receiving indacaterol and salmeterol; the study is completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Indacaterol (indacaterol)
• Salbutamol (salbutamol)
• Salmeterol (salmeterol)

Snippet

Sponsor: Novartis | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-05-23